Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients

被引：0
|
作者：
Christina Rennie
Andrew Lotery
Jo Payne
Moushmi Singh
Faruque Ghanchi
机构：
[1] University Hospital Southampton NHS Foundation Trust,
[2] Faculty of Medicine,undefined
[3] University of Southampton,undefined
[4] AbbVie Ltd,undefined
[5] AbbVie House,undefined
[6] Vanwall Business Park,undefined
[7] Bradford Teaching Hospitals NHS Foundation Trust,undefined
来源：
Eye | 2024年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 223
页数：8
相关论文
共 50 条
  • [1] Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients
    Rennie, Christina
    Lotery, Andrew
    Payne, Jo
    Singh, Moushmi
    Ghanchi, Faruque
    EYE, 2024, 38 (01) : 215 - 223
  • [2] Anti-vascular endothelial growth factor for diabetic macular oedema
    Virgili, Gianni
    Parravano, Mariacristina
    Menchini, Francesca
    Evans, Jennifer R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [3] Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular oedema and its correlation with anti-vascular endothelial growth factor treatment outcomes
    El-Shazly, Sherien F.
    El-Bradey, Mohamed H.
    Tameesh, Mohamed K.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 (04): : 369 - 378
  • [4] Effect of treatment cost on persistence and adherence of anti-vascular endothelial growth factor treatment for diabetic macular oedema
    Vukicevic, Meri
    Jaross, Nandor
    Saeed, Marian
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 1016 - 1017
  • [5] Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy
    Chu-Hsuan Huang
    Chang-Hao Yang
    Yi-Ting Hsieh
    Chung-May Yang
    Tzyy-Chang Ho
    Tso-Ting Lai
    Scientific Reports, 11
  • [6] Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy
    Huang, Chu-Hsuan
    Yang, Chang-Hao
    Hsieh, Yi-Ting
    Yang, Chung-May
    Ho, Tzyy-Chang
    Lai, Tso-Ting
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Anti-vascular endothelial growth factor treatment in diabetic macular edema
    Kim, Moosang
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1355 - 1356
  • [8] Diabetic Macular Oedema and Chronic Kidney Disease: Response to treatment with anti-vascular endothelial growth factor (VEGF)
    Bruynseels, Alice
    Pinto, Rita
    Sim, Dawn
    Rajendram, Ranjan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [9] Outcome of anti-vascular endothelial growth factor treatment for diabetic macular oedema during the COVID pandemic (Withdrawn)
    Khalid, Maham
    Richardson, Patrick
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 1022 - 1022
  • [10] Fluctuations in macular thickness in patients with diabetic macular oedema treated with anti-vascular endothelial growth factor agents
    Victoria Y. Wang
    Blanche L. Kuo
    Andrew X. Chen
    Kevin Wang
    Tyler E. Greenlee
    Thais F. Conti
    Rishi P. Singh
    Eye, 2022, 36 : 1461 - 1467
12345